维普中文期刊产品整合服务
43篇 您的检索式:作者名="Colevas"
    题名 作者 年代 出处 被引量
1基于IMRT时代的第八版AJCC/UICC鼻咽癌临床分期建议显示文摘目的准确的分期系统对癌症的治疗至关重要。随着癌症分期和治疗方法的演变,需要不断评价分期的适用性和改进性。方法基于第7版AJCC/UICC分期回顾性分析香港和中国大陆2个肿瘤中心收治的1609例接受调强放射治疗的首诊无转移鼻咽癌患者临床资料,所有患者治疗前均行核磁共振分期评估。结果无其他T3、T4期解剖结构受侵患者中,伴有咀嚼肌间隙(翼内肌和/或翼外肌)侵犯、椎前肌侵犯及咽旁间隙侵犯的三组患者之间0s相近。伴广泛软组织(上述侵犯结构以外的软组织)受侵患者OS与伴有颅内侵犯或颅神经侵犯相似。仅2%患者锁骨上窝以上淋巴结转移者直径〉6cm,其0s率与下颈淋巴结转移者类似。用下颈(环状软骨尾侧缘水平以下)代替锁骨上窝并不影响N分期之间的风险差异性。采用推荐的T、N分期,T。N。、T。N,期0s相近。结论经AJCC/UICC分期筹备委员会审阅后,建议第8版分期应将翼内肌/翼外肌从T。降到T:期,增加椎前肌为L期,用下颈取代锁骨上窝,将淋巴结最大直径〉6cm合并归为N,期,将T。、N,期统一归为Ⅳ。期。这些改变不仅使得相邻分期间风险差异性更好,而且使得临床实践性与全球适用性之间达到最佳平衡。潘建基 Wai Tong Ng 宗井凤 Lucy L.K.Chan Brian O' Sullivan 林少俊 Henry C.K.Sze 陈韵彬 Horace C.W.Choi 郭巧娟 Wai Kuen Kan 肖友平 Xu Wei Quynh Thu Le Christine M.Glastonbury A.Dimtrios Colevas Randal S.Weber Jatin P.Shah Anne W.M.Lee 2016中华放射肿瘤学杂志2016,25,3:65
2CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment显示文摘Andy Trotti A.Dimitrios Colevas Ann Setser Valerie Rusch David Jaques Volker Budach Corey Langer Barbara Murphy Richard Cumberlin C.Norman Coleman Philip Rubin 2003Seminars in Radiation Oncology2003,,3:8
3A Phase I / II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prog-nosis squamous cell carcinoma of the head and neck 显示文摘Tisher R Colevas AO Norris CM 2002Cancer2002,95,7:1
4Vitamin D levels,lung function,and steroid response in adult asthma显示文摘SUTHERLAND E R COLEVA E JACKSON L P 2010Am J Respir Crit Care Med2010,181,7:1
5Chemotherapy options for patients with metastaticor recurrenl: squamous cell carcinoma of the head and neck显示文摘Colevas AD 2006J ClinOncol2006,24,17:1
6Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck显示文摘Colevas AD 2006J Clin Onco12006,24,17:1
7Docetaxel, cisplatin, and 5 - fluorouracil - based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience显示文摘Haddad R Colevas AD Tishler R 2003Cancer2003,97,2:1
8Induction chemotherapy with docetaxel,cisplatin,fluorouracil,and leucovorin for squamous cell carcinoma of the head and neck:a phase Ⅰ /Ⅱ trial显示文摘 Busse PM Norris CM 1998J Clin Oncol1998,16,:1
9Phase Ⅱ trial of docetaxel,cisplatin,fluorouracil,and leucovorin as induction for squamous cell carcinoma of the head and neck显示文摘 Norris CM Tishler RB 1999J Clin Oncol1999,17,:1
10Phase Ⅰ /Ⅱ trial of outpatient docetaxel,cisplatin,5-fluorouracil,leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)显示文摘 Norris CM Tishler RB 2002Am J Clin Oncol2002,25,:1
11Chemotherapy options for patients with metastatic or recurrent squmous cell carcinoma of the head and neck 显示文摘Colevas AD 2006J Clin Oncol2006,24,17:1
12Airway remodeling and lack ot bronchodilator response in steroid- resistant asthma 显示文摘Coleva E Pia J Boguniewicz J 2007Allergy Clin Immunol2007,120,5:1
13Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial显示文摘Colevas AD Busse PM Norris CM 1998J Clin Oncol1998,16,4:1
14Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial显示文摘Nancy Y Lee Qiang Zhang David G Pfister John Kim Adam S Garden James Mechalakos Kenneth Hu Quynh T Le A Dimitrios Colevas Bonnie S Glisson Anthony TC Chan K Kian Ang 2012Lancet Oncology2012,,2:1
15Docetaxel,cisplatin and 5-fluorouracil based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck:The Dana Farber Cancer Institute experience显示文摘 Colevas AD Tishler R 2002Cancer2002,97,:1
16Chemotherapy options for patients with meta- static or recurrent squamous eell carcinoma of the head and neck 显示文摘Colevas AD 2006J Clin Oncol2006,24,17:1
17Airway re- modeling and lack ot bronchodilator response in steroid-resistant Asthma显示文摘Coleva E Pia J Boguniewicz J 2007Allergy Clin Immunol2007,120,5:1
18Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients 显示文摘Gruber JJ Colevas AD 2015Oncologist2015,20,2:1
19The NCI common Terminology Criteria forAdverse Events (CTCAE) v310 is the new standard for oncology clinical trials显示文摘Colevas AD Setser A CTEP/NCI 2007Clin Oncol2007,22,14:1
20T regulatory cells in atopic dermatitis and subversion of their activity by superantigens显示文摘Ou LS Coleva E Hall C 2004J Allergy Clin Immunol2004,113,4:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费